[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Envveno Medical Corp (NVNO)

Envveno Medical Corp (NVNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,944
  • Shares Outstanding, K 668
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,470 K
  • EBIT $ -20 M
  • EBITDA $ -20 M
  • 60-Month Beta 1.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.29

Options Overview Details

View History
  • Implied Volatility 0.00% (unch)
  • Historical Volatility 65.98%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Expected Move (DTE 0) 0.00 (0.00%)
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A
  • Expected Range 10.24 to 10.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $-11.58
  • Growth Rate Est. (year over year) +8,726.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.85 +7.88%
on 07/27/26
12.30 -13.61%
on 07/06/26
-0.08 (-0.78%)
since 06/30/26
3-Month
9.01 +17.94%
on 05/12/26
12.30 -13.61%
on 07/06/26
+0.19 (+1.78%)
since 04/30/26
52-Week
8.67 +22.56%
on 02/17/26
179.55 -94.08%
on 08/06/25
-158.77 (-93.73%)
since 07/30/25

Most Recent Stories

More News
enVVeno Medical Highlights Newly Issued U.S. Patent Strengthening Competitive Position Ahead of Historic Pivotal Trial in Virtual Investor "What This Means" Segment

CEO Explains How Broad Patent Protection, Combined with First-Ever FDA IDE Approval, Positions enVVe® to Own a Multi-Billion-Dollar Venous Disease Market

NVNO : 10.63 (+2.18%)
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

New Patent Broadly Protects Core Technology Behind Potential First Non-Surgical Replacement Venous Valve

NVNO : 10.63 (+2.18%)
enVVeno Medical to Present in the Webull Corporate Connect Webinar Series

- Live webcast on Wednesday, June 24th at 2:00 PM ET

NVNO : 10.63 (+2.18%)
enVVeno Medical to Participate in the Virtual Investor Closing Bell Series

Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical, on Tuesday, June 9that 4:00 PM ET

NVNO : 10.63 (+2.18%)
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment

First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-surgical Replacement Venous Valve

NVNO : 10.63 (+2.18%)
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System

Company ended the first quarter with approximately $25 million in cash and investments

NVNO : 10.63 (+2.18%)
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve

First-in-Class enVVe system to be evaluated in TAVVE U.S. Pivotal Trial

NVNO : 10.63 (+2.18%)
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System

Company accelerated development of the enVVe® System, completing pre-clinical studies and progressing toward a 2026 pivotal trial initiation

NVNO : 10.63 (+2.18%)
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Company achieves minimum $1.00 closing bid for 10 consecutive business days; Nasdaq confirms matter is closed

NVNO : 10.63 (+2.18%)
enVVeno Medical Announces Reverse Stock Split

IRVINE, CA / ACCESS Newswire / January 15, 2026 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno Medical" or the "Company"), today announced that the Company's Board of Directors has approved a reverse...

NVNO : 10.63 (+2.18%)

Business Summary

enVVeno Medical Corporation is a medical device company. It focuses in the treatment of venous disease. enVVeno Medical Corporation, formerly known as Hancock Jaffe Laboratories Inc., is based in IRVINE, CA.

See More

Key Turning Points

3rd Resistance Point 11.18
2nd Resistance Point 10.94
1st Resistance Point 10.78
Last Price 10.63
1st Support Level 10.38
2nd Support Level 10.14
3rd Support Level 9.98

See More

52-Week High 179.55
Fibonacci 61.8% 114.27
Fibonacci 50% 94.11
Fibonacci 38.2% 73.95
Last Price 10.63
52-Week Low 8.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.